Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.02%
#3 Fabric Protocol Fabric Protocol +30.68%
#4 Nockchain Nockchain +19.84%
#5 Cysic Cysic +19.17%
#6 Bedrock Bedrock +18.72%
#7 Perle Perle +11.77%
#8 The Black Bull The Black Bull +10.40%
#9 FOLKS FOLKS +7.85%
#10 Epic Chain Epic Chain +7.11%
Coin of the day
EXOD EXOD
설정
언어
한국어
통화
USD
테마
Peak Bio, Inc. Peak Bio, Inc.

Peak Bio, Inc.

PKBO
주식 순위 #37553
Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical... Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical development phase, committed to devising treatments for critical, unmet medical needs in the realms of oncology and inflammatory disorders. The company harnesses its unique, proprietary toxin—known as PH-1 or Thailanstatin—a spliceosome modulator, to create its inaugural range of innovative Antibody-Drug Conjugate (ADC) therapies designed for cancer patients facing significant challenges. Additionally, Peak Bio's leading investigational drug, PHP-303, a small molecule, is on the verge of commencing a Phase II dose clinical trial for the rare condition Alpha1 anti-trypsin deficiency (AATD). The company's operations are situated in Palo Alto, California.
주가
$0.07
마지막 동기화: 2024-11-12
시가총액
$1.62M
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Peak Bio, Inc. (PKBO)

카테고리

Healthcare
Peak Bio, Inc. (PKBO)의 주가 이력
최고 종가: $0.07 (2024-11-01 기준)

최저 종가: $9.71 (2021-03-01 기준)
Peak Bio, Inc.의 주가 이력 (2021 ~ 2026)
연간 주가 성과
연도 성과
2024 -26.66%
2023 -98.23%
2022 -44.81%
2021 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE